Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion evidence source_evidence_literature NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion SIO_000772 24590266 NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion wasDerivedFrom befree-20150227 NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion wasGeneratedBy ECO_0000203 NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.